Genomines | $45,000,000 | (Sep 18, 2025)
Synthesize Bio | $10,000,000 | (Sep 18, 2025)
Moby | $5,000,000 | (Sep 18, 2025)
AccurKardia
United States
- New York, NY
- 22/06/2023
- Seed
- $2,700,000
AccurKardia delivers automated clinical-grade ECG interpretation software to cardiac monitoring companies, thereby expanding access to the benefits of remote cardiac care to millions of patients worldwide. AccurKardia combines proprietary AI and non-AI based techniques to provide near-real time ECG analytics in the cloud, on device, and at the edge. The Company is part of Cohort 3 of Mayo Clinic Platform_Accelerate and first 510(k) filing is under review by FDA.
- Industry Software Development
- Website https://www.accurkardia.com/
- LinkedIn https://www.linkedin.com/company/accurkardia/
Related People
Juan C JimenezCo Founder
United States -
ND
Founded in 2019, AccurKardia delivers automated clinical-grade ECG interpretation software to cardiac monitoring companies, thereby expanding access to the benefits of remote cardiac care to millions of patients worldwide. AccurKardia combines proprietary AI and non-AI based techniques to provide near-real time ECG analytics in the cloud, on device, and at the edge.
Invisible Technologies | $100,000,000 | (Sep 18, 2025)
Mueon Corporation | $15,500,000 | (Sep 18, 2025)
Stablecore | $20,000,000 | (Sep 18, 2025)
Envive AI | $15,000,000 | (Sep 18, 2025)
Turnout | $21,000,000 | (Sep 18, 2025)
Imagine Pediatrics | $67,000,000 | (Sep 18, 2025)
Rec Technologies | $11,000,000 | (Sep 18, 2025)